Kimera Labs, Inc. v. Jayashankar

CourtDistrict Court, S.D. Florida
DecidedApril 12, 2024
Docket1:23-cv-24655
StatusUnknown

This text of Kimera Labs, Inc. v. Jayashankar (Kimera Labs, Inc. v. Jayashankar) is published on Counsel Stack Legal Research, covering District Court, S.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kimera Labs, Inc. v. Jayashankar, (S.D. Fla. 2024).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF FLORIDA

CASE NO. 23-cv-24655-ALTMAN/Sanchez

KIMERA LABS, INC.,

Plaintiff,

v.

RAJ JAYASHANKAR, et al.,

Defendants. ___________________________/ ORDER

This case arises out of another case—Kimera Labs, Inc. v. Raj Jayashankar, et al., Case No. 21- cv-02137 (S.D. Cal. Dec. 28, 2021) (Anello, J.)—which is currently being litigated in the Southern District of California, see Non-Party Dr. Selinger’s Motion to Quash Subpoenas (the “Motion to Quash”) [ECF No. 1] at 3. In that California case, the Plaintiff (Kimera Labs, Inc.) alleges that the Defendants (Raj Jayashankar; Exocel Bio, Inc.; Alejandro Contreras; and Deb Hubers) “misappropriated Kimera’s trade secrets.” Ibid. Kimera claims that it has “developed a highly lucrative scientific trade secret process used to manufacture exosomes and exosome related products on commercial scale.” Kimera’s Motion for Leave to Depose Non-Party Witness Dr. Melissa Selinger (the “Motion to Depose”) [ECF No. 16] at 1. Kimera adds that the “Defendants stole Kimera’s process and customer list, used Kimera’s processes and information to develop their own exosomes and exosome related products, sold exosomes and exosome related products to Kimera’s customers, and generated millions in profits based on Kimera’s trade secrets.” Id. at 1–2. According to the Plaintiff, “[n]on-party Dr. Melissa Selinger . . . is a critical witness to the trade secret lawsuit between Kimera and Defendants because she was the person who gave Kimera’s trade secrets process to Defendants.” Id. at 2. Kimera “requested that Dr. Selinger be deposed” in October of 2023, and “Dr. Selinger agreed to be deposed on December 15, 2023.” Motion to Quash at 3. Kimera subsequently deposed Dr. Selinger on February 22, 2024, and the Defendants deposed Dr. Selinger the very next day. See Motion to Depose at 2. On February 23, 2024, “Dr. Selinger agreed to sit for additional time, beyond the seven allotted hours, for Kimera to redirect,” and “Kimera’s counsel redirected Dr. Selinger on three significant factual issues important to Kimera’s case.” Non-Party Dr. Selinger’s Response in Opposition to Kimera’s Motion for Leave to Depose Dr. Selinger (the “Selinger

Response”) [ECF No. 19] at 5.1 These “back-to-back depositions total[ed] over 14 hours[.]” Ibid. Nonetheless, Kimera now seeks our leave to depose Dr. Selinger for two additional hours, see Motion to Depose at 4, because “Dr. Selinger resides more than 100 miles from Southern District of California’s Courthouse and probably cannot be compelled to testify at trial,” id. at 3; see also FED. R. CIV. P. 45(c)(1)(A) (“A subpoena may command a person to attend a trial, hearing, or deposition only as follows: (A) within 100 miles of where the person resides, is employed, or regularly transacts business in person . . . .”). Dr. Selinger and the Defendants oppose this request and have filed separate responses expressing their opposition. See generally Selinger Response; Defendants’ Response in Opposition to Kimera’s Motion for Leave to Depose Non-Party Witness Dr. Selinger (the “Defendants’ Response”) [ECF No. 20]. This Order follows. THE LAW Unless otherwise “stipulated or ordered” by the court, “a deposition is limited to 1 day of 7

hours.” FED. R. CIV. P. 30(d)(1). The Advisory Committee Notes to Rule 30 provide that “[t]he party seeking a court order to extend [a deposition], or otherwise alter the limitations, is expected to show good cause to justify such an order.” FED. R. CIV. P. 30 advisory committee’s notes. “The

1 Kimera, of course, rejects this characterization. See Kimera’s Reply in Support of its Motion to Depose (the “Reply”) [ECF No. 24] at 6 (claiming that its “so-called re-direct examination can hardly be characterized as thorough, complete, sufficient, or adequate”). 2 determination of whether good cause exists is fact specific,” Margel v. E. G.L. Gem Lab Ltd., 2008 WL 2224288, at *8 (S.D.N.Y. May 29, 2008), and “the availability of a second deposition is left to the sound discretion of the district court,” C.H. by Hilligloss v. Sch. Bd. of Okaloosa Cnty., Fla., 2021 WL 8918070, at *2 (N.D. Fla. July 19, 2021) (Cannon, Mag. J.) (cleaned up). While Rule 30 requires the court to “allow additional time . . . if needed to fairly examine the deponent,” it also requires the court to limit cumulative, duplicative, or burdensome discovery, “consistent with Rule 26(b)(1) and (2).”

FED. R. CIV. P. 30(d)(1); see also Kleppinger v. Tex. Dep’t of Transp., 283 F.R.D. 330, 333 (S.D. Tex. 2012) (“Rule 30(d)(1), similar to Rule 30(a)(2), requires a court to guard against redundant or disproportionate discovery, stating that any additional deposition time must be consistent with Rule 26(b)(2).”).2 ANALYSIS Having carefully reviewed the Motion to Depose, the Responses, the Reply, and the governing law, we now DENY the Motion to Depose for three reasons. First, far from being deprived of an opportunity to depose Dr. Selinger, Kimera has already deposed Dr. Selinger for over seven hours—longer than the time prescribed by Rule 30 of the Federal Rules of Civil Procedure. See Motion to Depose at 2 (acknowledging that Kimera’s deposition of Dr. Selinger on February 22, 2024, “lasted for seven hours”); see also Reply at 5 (noting that Kimera re-

2 Under Federal Rule of Civil Procedure 26:

[T]he court must limit the frequency or extent of discovery otherwise allowed by these rules or by local rule if it determines that: (i) the discovery sought is unreasonably cumulative or duplicative, or can be obtained from some other source that is more convenient, less burdensome, or less expensive; (ii) the party seeking discovery has had ample opportunity to obtain the information by discovery in the action; or (iii) the proposed discovery is outside the scope permitted by Rule 26(b)(1).

FED. R. CIV. P. 26(b)(2)(C). 3 directed Dr. Selinger for “approximately two minutes” on February 23, 2024, but lamenting that “Kimera’s re-direct examination was only 1.6% of the total cross-examination time”). While Kimera concedes that it deposed Dr. Selinger for a full seven hours, it insists that “time was wasted” because “Defendants (through counsel) continuously interrupted . . . by interposing long-winded objections,” and “even more time was wasted due to technical issues such as low battery warnings and disruptive noises.” Motion to Depose at 7–8; see also id. at 2 (“Although the deposition arguably lasted for seven

hours, significant time loss occurred through no fault of Kimera.” (emphasis added)). But these are relatively routine problems that (for better or worse) afflict most (if not all) depositions. And we don’t, like a chess clock, pause one side’s time whenever the other party objects to a question. On the contrary, where “it is undisputed that [a deponent] was deposed for slightly more than seven hours,” courts routinely “find[ ] that an additional deposition [ ]—beyond the already expended seven-plus hours—is unwarranted.” Adelson v. Berkshire Life Ins. Co. of Am., 2022 WL 19404235, at *2 (S.D. Fla. Feb. 10, 2022) (Valle, Mag. J.). This is true even when a deponent is a “central figure in a case.” C.H. by Hilligloss, 2021 WL 8918070, at *3 (“The fact that Gilmore is a material witness does not justify going beyond the agreed upon time or the seven-hour time limit.”). Second, and relatedly, we’re unpersuaded by the Plaintiff’s argument that it’s entitled to two more hours of deposition time to “perform a re-direct examination of Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Chrysler International Corp. v. John Chemaly
280 F.3d 1358 (Eleventh Circuit, 2002)
Larry Bonner v. City of Prichard, Alabama
661 F.2d 1206 (Eleventh Circuit, 1981)
Kleppinger v. Texas Department of Transportation
283 F.R.D. 330 (S.D. Texas, 2012)
Smith v. Royal Caribbean Cruises, Ltd.
302 F.R.D. 688 (S.D. Florida, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
Kimera Labs, Inc. v. Jayashankar, Counsel Stack Legal Research, https://law.counselstack.com/opinion/kimera-labs-inc-v-jayashankar-flsd-2024.